找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

SCIE期刊JACC: CardioOncology 2024/2025影响因子:12.101 (JACC-CARDIOONCOL) (2666-0873). (ONCOLOGY)(肿瘤学)Science Citation Index E

[复制链接]
楼主: 万灵药
发表于 2025-3-23 09:46:43 | 显示全部楼层
Submitted on: 19 September 2010. Revised on: 21 October 2010. Accepted on: 18 December 2010. ___________________JACC: CardioOncology---ELSEVIER
发表于 2025-3-23 17:57:24 | 显示全部楼层
Submitted on: 12 June 2017. Revised on: 01 September 2017. Accepted on: 26 October 2017. ___________________JACC: CardioOncology---ELSEVIER
发表于 2025-3-23 20:33:56 | 显示全部楼层
Submitted on: 11 September 2009. Revised on: 08 October 2009. Accepted on: 01 November 2009. ___________________JACC: CardioOncology---ELSEVIER
发表于 2025-3-24 01:38:41 | 显示全部楼层
Submitted on: 30 August 2017. Revised on: 22 December 2017. Accepted on: 16 February 2018. ___________________JACC: CardioOncology---ELSEVIER
发表于 2025-3-24 03:05:34 | 显示全部楼层
Submitted on: 06 August 2002. Revised on: 15 October 2002. Accepted on: 30 November 2002. ___________________JACC: CardioOncology---ELSEVIER
发表于 2025-3-24 08:33:46 | 显示全部楼层
Submitted on: 28 November 2010. Revised on: 17 March 2011. Accepted on: 12 April 2011. ___________________JACC: CardioOncology---ELSEVIER
发表于 2025-3-24 13:26:29 | 显示全部楼层
Submitted on: 15 February 2023. Revised on: 16 May 2023. Accepted on: 11 June 2023. ___________________JACC: CardioOncology---ELSEVIER
发表于 2025-3-24 16:56:09 | 显示全部楼层
Submitted on: 04 July 1998. Revised on: 21 October 1998. Accepted on: 08 November 1998. ___________________JACC: CardioOncology---ELSEVIER
发表于 2025-3-24 21:12:15 | 显示全部楼层
Submitted on: 03 June 2003. Revised on: 01 July 2003. Accepted on: 19 August 2003. ___________________JACC: CardioOncology---ELSEVIER
发表于 2025-3-25 01:22:04 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-14 22:14
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表